Minna Oksanen

2.0k total citations
24 papers, 884 citations indexed

About

Minna Oksanen is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Minna Oksanen has authored 24 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 20 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Minna Oksanen's work include Virus-based gene therapy research (22 papers), CAR-T cell therapy research (20 papers) and Viral Infectious Diseases and Gene Expression in Insects (11 papers). Minna Oksanen is often cited by papers focused on Virus-based gene therapy research (22 papers), CAR-T cell therapy research (20 papers) and Viral Infectious Diseases and Gene Expression in Insects (11 papers). Minna Oksanen collaborates with scholars based in Finland, Germany and Sweden. Minna Oksanen's co-authors include Akseli Hemminki, Anna Kanerva, Timo Joensuu, Ilkka Liikanen, Anniina Koski, Vincenzo Cerullo, Otto Hemminki, Kaarina Partanen, Iulia Diaconu and Kalevi Kairemo and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Minna Oksanen

22 papers receiving 876 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Minna Oksanen 726 666 367 210 187 24 884
Timo Joensuu 716 1.0× 668 1.0× 367 1.0× 190 0.9× 176 0.9× 27 893
Sari Pesonen 734 1.0× 629 0.9× 448 1.2× 213 1.0× 206 1.1× 24 947
Mari Hirvinen 651 0.9× 550 0.8× 361 1.0× 236 1.1× 196 1.0× 19 878
Lotta Kangasniemi 840 1.2× 685 1.0× 542 1.5× 145 0.7× 243 1.3× 24 1.0k
João M. Santos 691 1.0× 823 1.2× 336 0.9× 366 1.7× 212 1.1× 39 1.1k
Sari Pesonen 659 0.9× 700 1.1× 537 1.5× 125 0.6× 219 1.2× 33 1.1k
Padma Sampath 517 0.7× 597 0.9× 280 0.8× 327 1.6× 112 0.6× 19 843
Roshni Ravindranathan 727 1.0× 805 1.2× 337 0.9× 432 2.1× 157 0.8× 17 1.1k
Mikko Siurala 694 1.0× 846 1.3× 328 0.9× 300 1.4× 198 1.1× 26 986
Candice Willmon 566 0.8× 409 0.6× 272 0.7× 132 0.6× 133 0.7× 17 683

Countries citing papers authored by Minna Oksanen

Since Specialization
Citations

This map shows the geographic impact of Minna Oksanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minna Oksanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minna Oksanen more than expected).

Fields of papers citing papers by Minna Oksanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minna Oksanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minna Oksanen. The network helps show where Minna Oksanen may publish in the future.

Co-authorship network of co-authors of Minna Oksanen

This figure shows the co-authorship network connecting the top 25 collaborators of Minna Oksanen. A scholar is included among the top collaborators of Minna Oksanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minna Oksanen. Minna Oksanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liikanen, Ilkka, Dafne C.A. Quixabeira, Otto Hemminki, et al.. (2022). Oncolytic adenovirus decreases the proportion of TIM-3+ subset of tumor-infiltrating CD8+ T cells with correlation to improved survival in patients with cancer. Journal for ImmunoTherapy of Cancer. 10(2). e003490–e003490. 18 indexed citations
2.
Hemminki, Otto, Minna Oksanen, Ilkka Liikanen, et al.. (2018). Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy. Molecular Therapy — Oncolytics. 9. 41–50. 7 indexed citations
3.
Liikanen, Ilkka, Siri Tähtinen, Kilian Guse, et al.. (2016). Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer. Molecular Cancer Therapeutics. 15(9). 2259–2269. 30 indexed citations
4.
Liikanen, Ilkka, Anniina Koski, Raita Heiskanen, et al.. (2016). Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy. Molecular Therapy. 24(7). 1323–1332. 30 indexed citations
5.
Bramante, Simona, Anniina Koski, Ilkka Liikanen, et al.. (2015). Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer. OncoImmunology. 5(2). e1078057–e1078057. 36 indexed citations
6.
Liikanen, Ilkka, Anniina Koski, Otto Hemminki, et al.. (2015). Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy. OncoImmunology. 4(3). e989771–e989771. 53 indexed citations
7.
Koski, Anniina, Simona Bramante, Anja Kipar, et al.. (2015). Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues. Molecular Therapy. 23(10). 1641–1652. 24 indexed citations
8.
Liikanen, Ilkka, Juuso Juhila, Riku Turkki, et al.. (2015). Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus. Molecular Therapy. 24(1). 175–183. 25 indexed citations
9.
Bramante, Simona, Johanna K. Kaufmann, Ville Veckman, et al.. (2015). Abstract B51: Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans. Cancer Immunology Research. 3(10_Supplement). B51–B51.
10.
Bramante, Simona, Johanna K. Kaufmann, Ville Veckman, et al.. (2015). Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM‐CSF: Results in vitro, in rodents and in humans. International Journal of Cancer. 137(7). 1775–1783. 41 indexed citations
11.
Kanerva, Anna, Anniina Koski, Ilkka Liikanen, et al.. (2014). Case–Control Estimation of the Impact of Oncolytic Adenovirus on the Survival of Patients With Refractory Solid Tumors. Molecular Therapy. 23(2). 321–329. 12 indexed citations
12.
Kanerva, Anna, Petri Nokisalmi, Iulia Diaconu, et al.. (2013). Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus. Clinical Cancer Research. 19(10). 2734–2744. 144 indexed citations
13.
Hirvinen, Mari, Raita Heiskanen, Minna Oksanen, et al.. (2013). Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment. Journal of Translational Medicine. 11(1). 193–193. 15 indexed citations
14.
Liikanen, Ilkka, Laura Ahtiainen, Mari Hirvinen, et al.. (2013). Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients. Molecular Therapy. 21(6). 1212–1223. 139 indexed citations
15.
Koski, Anniina, Heidi Liljenbäck, Anne Roivainen, et al.. (2013). [ 18 F]-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography in Response Evaluation of Oncolytic Adenovirus Treatments of Patients with Advanced Cancer. Human Gene Therapy. 24(12). 1029–1041. 21 indexed citations
16.
Pesonen, Sari, Iulia Diaconu, Lotta Kangasniemi, et al.. (2012). Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients. Cancer Research. 72(7). 1621–1631. 107 indexed citations
17.
Raki, Mari, Merja Särkioja, Sophie Escutenaire, et al.. (2011). Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients. The Journal of Gene Medicine. 13(5). 253–261. 28 indexed citations
18.
Escutenaire, Sophie, Vincenzo Cerullo, Iulia Diaconu, et al.. (2011). In vivoandin vitrodistribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments. Annals of Medicine. 43(2). 151–163. 18 indexed citations
19.
Myllykangas, Liisa, Tiina Paunio, Annukka Marjamaa, et al.. (2010). Ulkomaiset lääkärit, hammaslääkärit ja tieteelliset jatko-opiskelijat Suomessa. 41. 3309–3314.
20.
Pesonen, Sari, Heikki Helin, Petri Nokisalmi, et al.. (2010). Oncolytic adenovirus treatment of a patient with refractory neuroblastoma. Acta Oncologica. 49(1). 120–122. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timo Joensuu Breakdown of academic impact, for papers by Sari Pesonen Breakdown of academic impact, for papers by Mari Hirvinen Breakdown of academic impact, for papers by Lotta Kangasniemi Breakdown of academic impact, for papers by João M. Santos Breakdown of academic impact, for papers by Sari Pesonen Breakdown of academic impact, for papers by Padma Sampath Breakdown of academic impact, for papers by Roshni Ravindranathan Breakdown of academic impact, for papers by Mikko Siurala Breakdown of academic impact, for papers by Candice Willmon
Rankless by CCL
2026